BAKER BROS. ADVISORS LP 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-25 4:28 pm Purchase | 2024-03-21 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 2,070,544 9.990% | 82,842 (+4.17%) | Filing |
| 2023-11-21 5:24 pm Sale | 2023-11-17 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,987,702 9.990% | -28,058 (-1.39%) | Filing |
| 2023-10-05 4:36 pm Purchase | 2023-10-03 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 2,015,760 9.990% | 470,647 (+30.46%) | Filing |
| 2023-08-08 5:16 pm Unchanged | 2023-08-07 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 8.400% | 0 (Unchanged) | Filing |
| 2023-06-16 7:18 pm Unchanged | 2023-06-15 | 13D | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 8.400% | 0 (Unchanged) | Filing |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | MADRIGAL PHARMACEUTICALS INC C MDGL | BAKER BROS. ADVISORS LP | 1,545,113 9.000% | 45,900 (+3.06%) | Filing |